Results were reported as median and interquartile range (IQR) or frequency and percentage, as appropriate. Plasma viral suppression was defined as HIV-1 RNA < 50 copies/ml. McNemar and Wilcoxon signed-rank tests were used, as appropriate, to compare the outcomes before and after DTG. Multivariate linear regression examined factors that were correlated with the change in PHQ-9 scores between the 1st and 2nd assessment. Statistical analyses were performed using SPSS Version 18.0 (IBM Corp., Armonk, NY).
Chan P., Goh O., Kroon E., Colby D., Sacdalan C., Pinyakorn S., Prueksakaew P., Reiss P., Ananworanich J., Valcour V., Spudich S, & Paul R. (2020). Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort. AIDS Research and Therapy, 17, 1.
Corresponding Organization : University of Missouri–St. Louis
Other organizations :
Thai Red Cross Society, Henry M. Jackson Foundation, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Walter Reed Army Institute of Research, University Memory and Aging Center, University of California, San Francisco, Cognitive Research (United States), Yale University
Change in PHQ-9 scores between the 1st and 2nd assessment
control variables
Not explicitly mentioned
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
